Hetero Healthcare Ltd. (INDIA)
Velasof
Velasof contains Drug / Molecule called “Velpatasvir & sofosbuvir”. Velasof has high overall cure rates of 99% for GT2 patients† and 95% for GT3 patients‡. Velpanat was also found to be highly effective in patients with GT1, GT4, GT5 and GT6, with overall cure rates ranging from 97–100%.
Indication
Velasof is helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.
Note
Precaution
- Velasof is a prescription drug and should be used under proper medical guidance and advice.
- Caution should be exercised in patients with history of stomach problem, liver, kidney, or heart disease during pregnancy and breastfeeding.
Strength
100 mg Velpatasvir / 400 mg Sofosbuvir
Packing
1 X 28 Tablets (Plastic Container)
Storage
Store at room temperature (25 C).
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Velpanat
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
Hetero Healthcare Ltd. (INDIA)
Ledifos
Mylan
Mydacla
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)